1-(8-phosphonooctyl)-7-deazaxanthine

structure in first source

Also Known As:

TP65

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Balzarini, Jan: 1 article (01/2002)
2.	Bilsen, Filip: 1 article (01/2002)
3.	Camarasa, María José: 1 article (01/2002)
4.	De Clercq, Erik: 1 article (01/2002)
5.	Liekens, Sandra: 1 article (01/2002)
6.	Priego, Eva María: 1 article (01/2002)
7.	Pérez-Pérez, María Jesús: 1 article (01/2002)

1.	Neoplasms (Cancer) 01/02/2002 - "TP65 thus emerges as a potent and specific inhibitor of TP and TP-induced angiogenesis, which opens new perspectives for multi-substrate analogue inhibitors of TP as potential anti-cancer agents and as inhibitors of angiogenesis and of diseases with enhanced expression of TP."